sumeyra cetinkaya

Dr. sumeyra cetinkaya

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2021 in Molecules
Verified
Journal Article
Open access
PDF file
ISIpek Suntar
Ipek Suntar
SCsumeyra cetinkaya
sumeyra cetinkaya
EPEmiliano Panieri
Emiliano Panieri
Luciano SasoLuciano Saso
Luciano Saso
Brigitta ButtariBrigitta Buttari
Brigitta Buttari
EPElisabetta Profumo
Elisabetta Profumo
Wound healing involves a series of cellular events in damaged cells and tissues initiated with hemostasis and finally culminating with the formation of a fibrin clot. However, delay in the normal wound healing process during pathological conditions due to reactive oxygen species, inflammation and immune suppression at the wound site represents a medical challenge. So far, many therapeutic strategies have been developed to improve cellular homeostasis and chronic wounds in order to accelerate wound repair. In this context, the role of Nuclear factor erythroid 2-related factor 2 (Nrf2) during the wound healing process has been a stimulating research topic for therapeutic perspectives. Nrf2 is the main regulator of intracellular redox homeostasis. It increases cytoprotective gene expression and the antioxidant capacity of mammalian cells. It has been reported that some bioactive compounds attenuate cellular stress and thus accelerate cell proliferation, neovascularization and repair of damaged tissues by promoting Nrf2 activation. This review highlights the importance of the Nrf2 signaling pathway in wound healing strategies and the role of bioactive compounds that support wound repair through the modulation of this crucial transcription factor.

22 July 2021 in Nutrition and Cancer
Verified
Journal Article
Closed access
SCsumeyra cetinkaya
sumeyra cetinkaya
IAIlknur çınar ayan
Ilknur çınar ayan
ISİpEk Süntar
İpEk Süntar
HDHatice Gül Dursun
Hatice Gül Dursun
Liquidambar orientalis Mill. var. orientalis (Hammamelidaceae) commonly known as oriental sweet gum is a medicinal plant endemic to Turkey, and used for treatment of wounds such as ulcers, gastritis and skin diseases. However, there are only a limited number of studies on the anticancer properties of this plant. The aim of this study is to investigate the cellular and molecular mechanisms of L. orientalis in colorectal cancer cell lines and to reveal the active therapeutic components. Antioxidant, anti-proliferative, anti-invasive and apoptotic effects were investigated for determining biological activities. The phytochemical profile and quantitation assays were carried out by using HPLC-ESI-Q-TOF-MS. The results demonstrated that leaf methanol extract (LM) of L. orientalis has the highest cytotoxic activity in HCT-116 (IC50 27.80 μg/mL) and HT-29 (IC50 43.13 μg/mL) cell lines as compared to the other extracts tested. Regarding chemical composition, quercetin 3-glucoside (61.005 ± 1.527 mg/g extract), chlorogenic acid (31.627 ± 0.970 mg/g extract), pyrogallol (9.950 ± 0.001 mg/g extract), epigallocatechin gallate (9.671 ± 0.004 mg/g extract), apigenin 7-O-glucoside (2.687 ± 0.027 mg/g extract), gallic acid (2.137 ± 0.012 mg/g extract), genistin (1.270 ± 0.027 mg/g extract), luteolin (0.055 ± 0.0005 mg/g extract) and kaempferol (0.506 ± 0.007 mg/g extract) were identified as the major phytochemical compounds. Our results showed that LM extract exhibited In Vitro cytotoxic and apoptotic properties.

1 May 2022 in Anti-Cancer Agents in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
IAIlknur çınar ayan
Ilknur çınar ayan
SCsumeyra cetinkaya
sumeyra cetinkaya
HDHatice G. Dursun
Hatice G. Dursun
CGCanan E. Güneş
Canan E. Güneş
SSSeda Sirin
Seda Sirin
Background: In the treatment of Colorectal Cancer (CRC), the search for new antineoplastic drugs with fewer side effects and more effectiveness continues. A significant part of these pursuits and efforts focus on medicinal herbs and plant components derived from these plants. A. ketenoglui is one of these medicinal plants, and its anticancer potential has never been studied before. Methods: The phenolic and flavonoid content, and antioxidant activity of A. ketenoglui extracts were determined. The phytochemical profiling and quantification analysis of major components were performed by HPLC-ESI-Q-TOF-MS. Cytotoxicity, proliferation, apoptosis and cell cycle were evaluated to reveal the anticancer activity of the extract on CRC cells (HCT 116 and HT-29). The determined anticancer activity was confirmed by mRNA (RT-qPCR) and protein (Western blotting) analyzes. Results: A. ketenoglui methanol extract was found to have high phenolic (281.89±0.23) and flavonoid (33.80±0.15) content and antioxidant activity (IC50 40.03±0.38). According to the XTT assay, the extract has strong cytotoxic activity (IC50 350 μM in HCT 116 and IC50 263 μM in HT-29 cell line). The compounds most commonly found in the plant are, in descending order, chlorogenic acid, apigenin, genistin, baicalin, eupatorin, casticin, and luteolin. In flowcytometric analysis, the extract was found to induce greater apoptosis and cell cycle arrest in both cell lines than in both control and positive control (casticin). According to the results of the mRNA expression analysis, the extract treatment upregulated the expression of the critical genes of the cell cycle and apoptosis, such as p53, p21, caspase-3, and caspase-9. In protein expression analysis, an increase in caspase-3 and p53 expression was observed in both cell lines treated with the extract. In addition, caspase-9 expression was increased in HT-29 cells. Conclusion: The findings show that A. ketenoglui has an anticancer potential by inducing apoptosis and arresting the cancer cell cycle and may be promising for CRC therapy. This potential of the plant is realized through the synergistic effects of its newly identified components.

14 July 2024 in Journal of Applied Toxicology
Verified
Journal Article
Open access
EGEbru Güçlü
Ebru Güçlü
IAIlknur çınar ayan
Ilknur çınar ayan
SCsumeyra cetinkaya
sumeyra cetinkaya
HDHatice Gül Dursun
Hatice Gül Dursun
HVHasibe Cingilli Vural
Hasibe Cingilli Vural
The aim of this study was to evaluate the anticancer effects of piceatannol, a natural stilbenoid, on human neuroblastoma cells. In order to accomplish this goal, we performed various cellular assays, including the XTT cell proliferation assay for cell viability, colony formation assay for colony formation capacity, FITC Annexin V and cell death detection kit for apoptosis, matrigel invasion assay for invasion capacity, intracellular reactive oxygen species (ROS) red dye for intracellular ROS levels, TMRM staining method for mitochondrial membrane potential (MMP), and the CYTO‐ID autophagy detection kit for autophagy. Furthermore, we analyzed the expression levels of genes associated with apoptosis and autophagy using RT‐qPCR. Based on our findings, piceatannol exhibited cytotoxic effects on neuroblastoma cells. Besides, treatment with piceatannol at both 50 and 100 μM concentrations for 72 h decreased colony formation, induced apoptosis and autophagy, inhibited cell invasion, decreased MMP, and increased ROS levels in SH‐SY5Y cells. In addition, we observed significant upregulation in the expression levels of CASP8, BECLIN, ATG5, ATG7, and MAPILC3A genes between the two doses. These results suggest that piceatannol enhances autophagic activity and induces caspase‐dependent apoptosis, indicating its potential as a therapeutic agent against neuroblastoma cells.

1 December 2025 in Anti-Cancer Agents in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
SCsumeyra cetinkaya
sumeyra cetinkaya
IAIlknur çınar ayan
Ilknur çınar ayan
HDHatice Gul Dursun
Hatice Gul Dursun
ISIpek Suntar
Ipek Suntar
KTKEVSER TABAN
KEVSER TABAN
MAMithat Atak
Mithat Atak
Aims: This study explores the therapeutic potential of Nigella sativa L. and its key bioactive compound, thymoquinone (TQ). Background: Pancreatic cancer presents a significant health challenge due to its aggressiveness and limited treatment options. N. sativa and its component TQ have demonstrated anticancer properties in other cancers, warranting exploration in pancreatic cancer models. Objective: To assess the antiproliferative, apoptotic, and anti-invasive effects of N. sativa extracts and TQ on pancreatic cancer cells, with a focus on modulating the NRF2/HO-1 and TNF-α signaling pathways. Methods: MIA PaCa-2 and PANC-1 pancreatic cancer cell lines were treated with essential and fixed oils, methanol extracts (from Türkiye and Syria), and TQ. Cell viability, apoptosis, and invasiveness were assessed via XTT, Annexin V, and Matrigel assays, respectively. Gene expression and cytokine levels were evaluated using RTqPCR and ELISA. HPLC was conducted to confirm TQ concentrations in extracts. Results: The methanol extract of Türkiye-originated N. sativa seeds (TM) exhibited the highest cytotoxic effect, reducing cell viability in MIA PaCa-2 and PANC-1 at 0.05 mg/mL, while TQ significantly decreased viability at 20 μM. TM reduced MIA PaCa-2 and PANC-1 invasiveness (42±1.23 and 35±0.73, respectively) and contained a higher concentration of TQ (7.9168 ± 0.0561%) compared to the Syria-originated extract (SM). Conclusion: The findings suggest that TM and TQ exhibit strong anticancer potential by modulating key signaling pathways in pancreatic cancer cells, supporting their potential for further development as therapeutic agents in pancreatic cancer treatment.

6 February 2026 in International Journal of Food Sciences and Nutrition
Verified
Journal Article
Closed access
TSTuğba Subaş
Tuğba Subaş
SCsumeyra cetinkaya
sumeyra cetinkaya
SSSeda Sirin
Seda Sirin
TBTugce Baser
Tugce Baser
ISIpek Suntar
Ipek Suntar
Obesity and its associated metabolic disorders, including type 2 diabetes mellitus, non-alcoholic fatty liver disease, and cardiovascular complications, represent a major global health burden. A key pathogenic mechanism linking these conditions is the overactivation of the NLRP3 inflammasome, which triggers caspase-1 activation and promotes proinflammatory cytokine release (e.g., IL-1β and IL-18), driving adipose tissue dysfunction, insulin resistance, and systemic inflammation. Emerging evidence highlights dietary polyphenols as natural modulators of NLRP3 activity attenuating inflammasome activation by regulating NF-κB signalling, reducing oxidative stress and restoring autophagy. Complementary in silico approaches (e.g., molecular docking, molecular dynamics simulations, network pharmacology) provide mechanistic insights into polyphenol-inflammasome interactions. This review summarises current evidence on the NLRP3's role in obesity-related disorders and discusses the therapeutic potential of dietary polyphenols, underscoring directions for translational and multidisciplinary research.